• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌内注射干细胞治疗猪心肌梗死模型:韩国的首次试验。

Intramyocardial Injection of Stem Cells in Pig Myocardial Infarction Model: The First Trial in Korea.

机构信息

Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea.

Biomedical Research Institute, Chonnam National University Hospital, Gwangju, Korea.

出版信息

J Korean Med Sci. 2017 Oct;32(10):1708-1712. doi: 10.3346/jkms.2017.32.10.1708.

DOI:10.3346/jkms.2017.32.10.1708
PMID:28875618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5592188/
Abstract

Although cell therapy is emerged for cardiac repair, its efficacy is modest by intracoronary infusion. Therefore, we established the intramyocardial delivery technique using a left ventricular (LV) mapping system (NOGA® XP) using 18 pigs. After adipose tissue-derived mesenchymal stem cells (ATSCs) were delivered intramyocardially to porcine infarcted heart, LV ejection fraction (EF) was increased, and LV chamber size was decreased. We proved the therapeutic effect of intramyocardial injection of ATSC through a LV mapping system in the porcine model for the first time in Korea. The adoption of this technique may accelerate the translation into a clinical application in the near future.

摘要

虽然细胞疗法已应用于心梗修复,但通过冠状动脉内输注的疗效有限。因此,我们使用左心室(LV)映射系统(NOGA® XP)建立了心肌内递送技术,该技术使用了 18 头猪。将脂肪组织来源的间充质干细胞(ATSCs)心肌内递送到猪梗死心脏后,LV 射血分数(EF)增加,LV 室腔大小减小。我们首次在韩国通过 LV 映射系统证明了心肌内注射 ATSC 的治疗效果。该技术的应用可能会加速其在不久的将来在临床应用中的转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc58/5592188/13213a0d0ad8/jkms-32-1708-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc58/5592188/1dcfb1dac34c/jkms-32-1708-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc58/5592188/13213a0d0ad8/jkms-32-1708-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc58/5592188/1dcfb1dac34c/jkms-32-1708-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc58/5592188/13213a0d0ad8/jkms-32-1708-g002.jpg

相似文献

1
Intramyocardial Injection of Stem Cells in Pig Myocardial Infarction Model: The First Trial in Korea.心肌内注射干细胞治疗猪心肌梗死模型:韩国的首次试验。
J Korean Med Sci. 2017 Oct;32(10):1708-1712. doi: 10.3346/jkms.2017.32.10.1708.
2
Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction.在无免疫抑制情况下,心肌内注射同种异体骨髓间充质干细胞可在猪心肌梗死模型中保留心脏功能。
J Cardiovasc Pharmacol Ther. 2005 Dec;10(4):225-33. doi: 10.1177/107424840501000403.
3
Safety and efficacy of cardiopoietic stem cells in the treatment of post-infarction left-ventricular dysfunction - From cardioprotection to functional repair in a translational pig infarction model.心肌发生细胞治疗梗死后左心室功能障碍的安全性和有效性 - 从心脏保护到转化猪梗死模型中的功能修复。
Biomaterials. 2017 Apr;122:48-62. doi: 10.1016/j.biomaterials.2016.11.029. Epub 2016 Nov 23.
4
Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.与骨髓单个核细胞相比,经皮心肌内注射间充质干细胞可使猪心肌梗死心脏的局部左心室功能得到更显著的改善。
Theranostics. 2015 Jan 1;5(2):196-205. doi: 10.7150/thno.7976. eCollection 2015.
5
Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties.再灌注急性心肌梗死后早期静脉注射间充质干细胞疗法可改善左心室功能并改变电生理特性。
Int J Cardiol. 2006 Aug 10;111(2):231-9. doi: 10.1016/j.ijcard.2005.07.036. Epub 2005 Oct 24.
6
Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction.包封的胰高血糖素样肽-1 洗脱间充质干细胞经冠状动脉内输注可在猪急性心肌梗死模型中保护左心室功能。
Circ Cardiovasc Interv. 2014 Oct;7(5):673-83. doi: 10.1161/CIRCINTERVENTIONS.114.001580. Epub 2014 Oct 7.
7
Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.人脐带间充质基质细胞改善慢性心肌缺血猪模型的左心室功能、灌注及重塑
Stem Cells Transl Med. 2016 Aug;5(8):1004-13. doi: 10.5966/sctm.2015-0298. Epub 2016 Jun 22.
8
Transcatheter based electromechanical mapping guided intramyocardial transplantation and in vivo tracking of human stem cell based three dimensional microtissues in the porcine heart.基于导管的机电映射指导下的心肌内移植和体内跟踪猪心脏中人源干细胞三维微组织。
Biomaterials. 2013 Mar;34(10):2428-41. doi: 10.1016/j.biomaterials.2012.12.021. Epub 2013 Jan 16.
9
CXCR4 Antagonist TG-0054 Mobilizes Mesenchymal Stem Cells, Attenuates Inflammation, and Preserves Cardiac Systolic Function in a Porcine Model of Myocardial Infarction.CXCR4拮抗剂TG-0054可动员间充质干细胞,减轻炎症反应,并在猪心肌梗死模型中保留心脏收缩功能。
Cell Transplant. 2015;24(7):1313-28. doi: 10.3727/096368914X681739. Epub 2014 May 12.
10
Combined therapy with shock wave and autologous bone marrow-derived mesenchymal stem cells alleviates left ventricular dysfunction and remodeling through inhibiting inflammatory stimuli, oxidative stress & enhancing angiogenesis in a swine myocardial infarction model.在猪心肌梗死模型中,冲击波与自体骨髓间充质干细胞联合治疗通过抑制炎症刺激、氧化应激及增强血管生成来减轻左心室功能障碍和重塑。
Int J Cardiol. 2015 Aug 15;193:69-83. doi: 10.1016/j.ijcard.2015.03.044. Epub 2015 Mar 4.

引用本文的文献

1
Cell Therapy in the Treatment of Coronary Heart Disease.细胞疗法治疗冠心病
Int J Mol Sci. 2023 Nov 28;24(23):16844. doi: 10.3390/ijms242316844.
2
Large animal models of cardiac ischemia-reperfusion injury: Where are we now?心脏缺血再灌注损伤的大动物模型:我们现在在哪里?
Zool Res. 2023 May 18;44(3):591-603. doi: 10.24272/j.issn.2095-8137.2022.487.
3
Assessment of Myocardial Diastolic Dysfunction as a Result of Myocardial Infarction and Extracellular Matrix Regulation Disorders in the Context of Mesenchymal Stem Cell Therapy.

本文引用的文献

1
Evolving therapies for myocardial ischemia/reperfusion injury.心肌缺血/再灌注损伤的治疗进展。
J Am Coll Cardiol. 2015 Apr 14;65(14):1454-71. doi: 10.1016/j.jacc.2015.02.032.
2
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.基于个体患者数据的急性心肌梗死患者细胞心肌研究的荟萃分析(ACCRUE)
Circ Res. 2015 Apr 10;116(8):1346-60. doi: 10.1161/CIRCRESAHA.116.304346. Epub 2015 Feb 19.
3
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
间充质干细胞治疗背景下心肌梗死及细胞外基质调节紊乱所致心肌舒张功能障碍的评估
J Clin Med. 2022 Sep 15;11(18):5430. doi: 10.3390/jcm11185430.
4
Efficacy of Stem Cell Therapy in Large Animal Models of Ischemic Cardiomyopathies: A Systematic Review and Meta-Analysis.干细胞疗法在缺血性心肌病大型动物模型中的疗效:系统评价与荟萃分析
Animals (Basel). 2022 Mar 16;12(6):749. doi: 10.3390/ani12060749.
5
Current Status and Limitations of Myocardial Infarction Large Animal Models in Cardiovascular Translational Research.心肌梗死大动物模型在心血管转化研究中的现状与局限性
Front Bioeng Biotechnol. 2021 Apr 29;9:673683. doi: 10.3389/fbioe.2021.673683. eCollection 2021.
6
Xenogeneic and Stem Cell-Based Therapy for Cardiovascular Diseases: Genetic Engineering of Porcine Cells and Their Applications in Heart Regeneration.用于心血管疾病的异种和基于干细胞的疗法:猪细胞的基因工程及其在心脏再生中的应用
Int J Mol Sci. 2020 Dec 18;21(24):9686. doi: 10.3390/ijms21249686.
7
Main histological parameters to be evaluated in an experimental model of myocardial infarct treated by stem cells on pigs.在猪的心肌梗死干细胞治疗实验模型中待评估的主要组织学参数。
PeerJ. 2019 Jul 22;7:e7160. doi: 10.7717/peerj.7160. eCollection 2019.
8
Age-Appropriateness of Porcine Models Used for Cell Transplantation.用于细胞移植的猪模型的年龄适宜性。
Cell Transplant. 2019 Feb;28(2):224-228. doi: 10.1177/0963689718817477. Epub 2018 Dec 10.
9
Functional Relevance of Macrophage-mediated Inflammation to Cardiac Regeneration.巨噬细胞介导的炎症与心脏再生的功能相关性
Chonnam Med J. 2018 Jan;54(1):10-16. doi: 10.4068/cmj.2018.54.1.10. Epub 2018 Jan 25.
经心内膜心肌间质干细胞和单核骨髓细胞治疗缺血性心肌病:TAC-HFT 随机试验。
JAMA. 2014 Jan 1;311(1):62-73. doi: 10.1001/jama.2013.282909.
4
Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin.催产素恢复糖尿病损伤间充质干细胞的血管生成能力
BMC Cell Biol. 2013 Sep 11;14:38. doi: 10.1186/1471-2121-14-38.
5
Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.心力衰竭中心肌发生干细胞治疗:C-CURE(心力衰竭中心肌发生干细胞治疗)多中心随机试验与谱系特异性生物制剂。
J Am Coll Cardiol. 2013 Jun 11;61(23):2329-38. doi: 10.1016/j.jacc.2013.02.071. Epub 2013 Apr 10.
6
Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes.自体骨髓干细胞治疗急性心肌梗死的长期疗效:可能影响疗效的因素。
PLoS One. 2012;7(5):e37373. doi: 10.1371/journal.pone.0037373. Epub 2012 May 24.
7
Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.间质干细胞:生物学、病理生理学、转化研究结果以及在心脏疾病中的治疗意义。
Circ Res. 2011 Sep 30;109(8):923-40. doi: 10.1161/CIRCRESAHA.111.243147.
8
Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the korean heart failure registry.急性心力衰竭住院患者的长期死亡率的特征、结局和预测因素:韩国心力衰竭登记处的报告。
Korean Circ J. 2011 Jul;41(7):363-71. doi: 10.4070/kcj.2011.41.7.363. Epub 2011 Jul 30.
9
Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease.3D-NOGA 图谱在缺血性心脏病中的诊断和预后价值。
Nat Rev Cardiol. 2011 May 17;8(7):393-404. doi: 10.1038/nrcardio.2011.64.
10
Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling.心肌内干细胞注射治疗缺血性心肌病:功能恢复和逆向重构。
Circ Res. 2011 Apr 1;108(7):792-6. doi: 10.1161/CIRCRESAHA.111.242610. Epub 2011 Mar 17.